Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease.
Hannah JR, Lawrence A, Martinovic J, Naqvi M, Chua F, Kouranos V, Ali SS, Stock C, Owens C, Devaraj A, Pollard L, Agarwal S, Atienza-Mateo B, González-Gay MA, Patel A, West A, Tinsley K, Robbie H, Lams B, Wells AU, Norton S, Galloway J, Renzoni EA, Gordon PA. Hannah JR, et al. Among authors: stock c. Rheumatology (Oxford). 2023 Dec 1:kead638. doi: 10.1093/rheumatology/kead638. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38039151
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, Spagnolo P, Pantelidis P, Leoni P, McHugh N, Stock CJ, Shi-Wen X, Denton CP, Black CM, Welsh KI, du Bois RM, Abraham DJ. Fonseca C, et al. Among authors: stock cj. N Engl J Med. 2007 Sep 20;357(12):1210-20. doi: 10.1056/NEJMoa067655. N Engl J Med. 2007. PMID: 17881752 Free article.
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Lindahl GE, Renzoni EA. Stock CJ, et al. Thorax. 2013 May;68(5):436-41. doi: 10.1136/thoraxjnl-2012-201786. Epub 2013 Jan 15. Thorax. 2013. PMID: 23321605 Free article.
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.
Lindahl GE, Stock CJ, Shi-Wen X, Leoni P, Sestini P, Howat SL, Bou-Gharios G, Nicholson AG, Denton CP, Grutters JC, Maher TM, Wells AU, Abraham DJ, Renzoni EA. Lindahl GE, et al. Among authors: stock cj. Respir Res. 2013 Aug 2;14(1):80. doi: 10.1186/1465-9921-14-80. Respir Res. 2013. PMID: 23915349 Free PMC article.
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.
Conti C, Montero-Fernandez A, Borg E, Osadolor T, Viola P, De Lauretis A, Stock CJ, Bonifazi M, Bonini M, Caramori G, Lindahl G, Blasi FB, Nicholson AG, Wells AU, Sestini P, Renzoni E. Conti C, et al. Among authors: stock cj. Am J Respir Crit Care Med. 2016 Feb 15;193(4):462-4. doi: 10.1164/rccm.201507-1322LE. Am J Respir Crit Care Med. 2016. PMID: 26871672 Free article. No abstract available.
Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
Molyneaux PL, Willis-Owen SAG, Cox MJ, James P, Cowman S, Loebinger M, Blanchard A, Edwards LM, Stock C, Daccord C, Renzoni EA, Wells AU, Moffatt MF, Cookson WOC, Maher TM. Molyneaux PL, et al. Among authors: stock c. Am J Respir Crit Care Med. 2017 Jun 15;195(12):1640-1650. doi: 10.1164/rccm.201607-1408OC. Am J Respir Crit Care Med. 2017. PMID: 28085486 Free PMC article.
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.
Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA. Visca D, et al. Among authors: stock cjw. Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28. Lancet Respir Med. 2018. PMID: 30170904 Free article. Clinical Trial.
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease.
Alfieri V, Crisafulli E, Visca D, Chong WH, Stock C, Mori L, de Lauretis A, Tsipouri V, Chua F, Kouranos V, Kokosi M, Hogben C, Molyneaux PL, George PM, Maher TM, Chetta AA, Sestini P, Wells AU, Renzoni EA. Alfieri V, et al. Among authors: stock c. Eur Respir J. 2020 Feb 20;55(2):1901681. doi: 10.1183/13993003.01681-2019. Print 2020 Feb. Eur Respir J. 2020. PMID: 31699833 Free article. No abstract available.
765 results